Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Byline Bancorp | BY | Jan 17, 2025 | 28.51 | +1.14 |
byNordic Acquisition A | BYNO | Jan 17, 2025 | 11.37 | 0.00 |
Byrna Technologies | BYRN | Jan 17, 2025 | 29.40 | +0.55 |
C&F Financial | CFFI | Jan 17, 2025 | 74.12 | +3.71 |
C.H. Robinson Worldwide | CHRW | Jan 17, 2025 | 103.58 | +0.87 |
C3.ai | AI | Jan 17, 2025 | 32.01 | -0.93 |
C3is | CISS | Jan 17, 2025 | 1.23 | -2.38 |
C4 Therapeutics | CCCC | Jan 17, 2025 | 3.94 | +2.07 |
Cabaletta Bio | CABA | Jan 17, 2025 | 2.74 | +12.76 |
Cabana Target Drawdown 10 ETF | TDSC | Jan 17, 2025 | 25.25 | +0.70 |
Cabana Target Drawdown 7 ETF | TDSB | Jan 17, 2025 | 21.99 | +0.59 |
Cable One | CABO | Jan 17, 2025 | 332.32 | +0.57 |
Cabot | CBT | Jan 17, 2025 | 91.27 | +1.19 |
CACI International A | CACI | Jan 17, 2025 | 452.39 | -0.42 |
Cactus A | WHD | Jan 17, 2025 | 63.63 | -0.24 |
Cactus Acquisition 1 A | CCTS | Jan 17, 2025 | 11.65 | 0.00 |
Cadeler ADR | CDLR | Jan 17, 2025 | 20.78 | -0.38 |
Cadence Bank | CADE | Jan 17, 2025 | 35.65 | +1.02 |
Cadence Bank A | CADE-A | Jan 17, 2025 | 21.35 | -0.33 |
Cadence Design Systems | CDNS | Jan 17, 2025 | 305.60 | +2.24 |
Cadiz | CDZI | Jan 17, 2025 | 5.17 | +4.77 |
Cadiz Pref ADR | CDZIP | Jan 17, 2025 | 18.40 | +1.66 |
Cadre | CDRE | Jan 17, 2025 | 38.19 | +6.00 |
Cadrenal Therapeutics | CVKD | Jan 17, 2025 | 17.40 | -4.40 |
Cae | CAE | Jan 17, 2025 | 24.16 | +0.42 |
Caesars Entertainment | CZR | Jan 17, 2025 | 34.05 | +2.19 |
Caesarstone | CSTE | Jan 17, 2025 | 4.20 | +0.48 |
Cal-Maine Foods | CALM | Jan 17, 2025 | 113.63 | +1.54 |
Calamos Convertible High Fund | CHY | Jan 17, 2025 | 11.65 | -0.26 |
Calamos Convertible Opportunities And Income Fund | CHI | Jan 17, 2025 | 11.54 | +0.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.